ECM
KPTI icon

ExodusPoint Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

ExodusPoint Capital Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-93,170
Closed -$1.87M – 1774
2023
Q3 		$1.87M Sell
93,170
-65,660
-41% -$1.47M 0.02% 697
2023
Q2 		$4.26M Buy
+158,830
New +$6.84M 0.03% 509
2023
Q1 		– Sell
-73,742
Closed -$3.76M – 1950
2022
Q4 		$3.76M Buy
73,742
+26,590
+56% +$1.84M 0.05% 429
2022
Q3 		$3.86M Buy
47,152
+4,086
+9% +$305K 0.05% 500
2022
Q2 		$2.91M Buy
43,066
+41,767
+3,215% +$3.83M 0.04% 625
2022
Q1 		$144K Sell
1,299
-5,961
-82% -$743K ﹤0.01% 1966
2021
Q4 		$700K Buy
7,260
+5,265
+264% +$525K 0.01% 1247
2021
Q3 		$174K Buy
1,995
+187
+10% +$19.4K ﹤0.01% 1811
2021
Q2 		$280K Buy
1,808
+81
+5% +$11.8K ﹤0.01% 1783
2021
Q1 		$273K Buy
+1,727
New +$364K ﹤0.01% 1731
2020
Q4 		– Sell
-1,513
Closed -$331K – 2179
2020
Q3 		$331K Buy
+1,513
New +$370K 0.01% 1234
2020
Q2 		– Sell
-1,917
Closed -$552K – 1909
2020
Q1 		$552K Buy
+1,917
New +$529K 0.03% 452
2019
Q4 		– Sell
-6,600
Closed -$952K – 1712
2019
Q3 		$952K Buy
6,600
+4,880
+284% +$662K 0.03% 404
2019
Q2 		$155K Buy
+1,720
New +$138K 0.01% 971

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ExodusPoint Capital Management's KPTI Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of Karyopharm Therapeutics (KPTI) in Q4 2023, closing a stake of 93,170 shares — an estimated $1.87M sold.

ExodusPoint Capital Management first reported a position in KPTI in Q2 2019 and held it in 14 quarters. The position peaked at $4.26M in Q2 2023. 117 funds tracked by Wall St. Rank hold KPTI as of Q4 2023.

  • ExodusPoint Capital Management reported no remaining Karyopharm Therapeutics position as of Q4 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 93,170 Karyopharm Therapeutics shares in Q4 2023, an estimated $1.87M.
  • ExodusPoint Capital Management first reported a position in Karyopharm Therapeutics in Q2 2019 and held it in 14 quarters.
  • ExodusPoint Capital Management's Karyopharm Therapeutics position peaked at $4.26M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.